Juvena Therapeutics

Juvena Therapeutics company information, Employees & Contact Information

Decoding Secreted Proteins for Chronic and Age-Related Diseases

Company Details

Employees
46
Founded
-
Address
Palo Alto, Ca 94304, Us
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Palo Alto, CA
Looking for a particular Juvena Therapeutics employee's phone or email?

Juvena Therapeutics Questions

News

NIA Small Business Showcase: Juvena Therapeutics, Inc. - National Institute on Aging (.gov)

NIA Small Business Showcase: Juvena Therapeutics, Inc. National Institute on Aging (.gov)

Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health - GlobeNewswire

Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health GlobeNewswire

Eli Lilly, Juvena Therapeutics Partner to Develop Muscle-Boosting Drugs Using AI Platform - Yahoo Finance

Eli Lilly, Juvena Therapeutics Partner to Develop Muscle-Boosting Drugs Using AI Platform Yahoo Finance

Best Kept Secret-Ome: Juvena Therapeutics and Lilly Partner on Muscle Health - Inside Precision Medicine

Best Kept Secret-Ome: Juvena Therapeutics and Lilly Partner on Muscle Health Inside Precision Medicine

Juvena Therapeutics and Lilly collaborate on muscle health drugs - The Pharma Letter

Juvena Therapeutics and Lilly collaborate on muscle health drugs The Pharma Letter

Juvena Therapeutics Secures $41 Million to Accelerate the Discovery and Development of Biologics for Chronic and Age-Related Diseases - Business Wire

Juvena Therapeutics Secures $41 Million to Accelerate the Discovery and Development of Biologics for Chronic and Age-Related Diseases Business Wire

How a daughter of refugees founded a biotech to combat diseases that have afflicted her family - The Business Journals

How a daughter of refugees founded a biotech to combat diseases that have afflicted her family The Business Journals

Biotech Startup Juvena Therapeutics Nabs $41 Million for Protein Drugs - The Wall Street Journal

Biotech Startup Juvena Therapeutics Nabs $41 Million for Protein Drugs The Wall Street Journal

Juvena Therapeutics Receives FDA Orphan Drug Designation for JUV-161 for the Treatment of Myotonic Dystrophy Type 1 - Business Wire

Juvena Therapeutics Receives FDA Orphan Drug Designation for JUV-161 for the Treatment of Myotonic Dystrophy Type 1 Business Wire

Top Juvena Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant